Set On Competing With Merck And Roche, Dr Reddy's Labs Pins Hopes On CETP Drug
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Despite the odds against developing a robust pipeline of innovative drugs, Kallam Anji Reddy, founder and chairman of the $1.36 billion Dr. Reddy's Labs, refuses to give up the chase to discover new drugs